Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
- Published In:
- Cell research, 30(4), 343-355 (2020)
- Authors:
- Xia, Shuai, Liu, Mingqi, Wang, Chao(3), Xu, Wei, Lan, Qiaoshuai, Feng, Siliang, Qi, Feifei, Bao, Linlin, Du, Lanying, Liu, Shuwen, Qin, Chuan, Sun, Fei, Shi, Zhengli, Zhu, Yun, Jiang, Shibo, Lu, Lu
- Database ID:
- RPEP-05205
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05205APA
Xia, Shuai; Liu, Mingqi; Wang, Chao; Xu, Wei; Lan, Qiaoshuai; Feng, Siliang; Qi, Feifei; Bao, Linlin; Du, Lanying; Liu, Shuwen; Qin, Chuan; Sun, Fei; Shi, Zhengli; Zhu, Yun; Jiang, Shibo; Lu, Lu. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.. Cell research, 30(4), 343-355. https://doi.org/10.1038/s41422-020-0305-x
MLA
Xia, Shuai, et al. "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.." Cell research, 2020. https://doi.org/10.1038/s41422-020-0305-x
RethinkPeptides
RethinkPeptides Research Database. "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by..." RPEP-05205. Retrieved from https://rethinkpeptides.com/research/xia-2020-inhibition-of-sarscov2-infection-by
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.